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Kinesiophobia, the fear of physical movement and activity related to injury vulnerability, has been 40 
linked to sub-optimal outcomes following total knee replacement (TKR). This systematic review has 41 
two aims: to define the relationship between kinesiophobia and functional outcomes, pain and 42 
range of motion following TKR, and to evaluate published treatments for kinesiophobia following 43 
TKR.  44 
 45 
Materials and Methods 46 
 47 
A primary search of electronic databases, grey literature, and trial registries was performed in March 48 
2020. English-language studies recruiting adult primary TKR patients, using the Tampa Scale of 49 
Kinesiophobia (TSK) were included. Outcome measures were grouped into short (<six months), 50 
medium (six-12 months), and long term (>12 months). Study quality was assessed using the 51 
Newcastle Ottawa Scale for cohort or case control studies, and the Cochrane Collaboration Risk of 52 




All thirteen included papers (82 identified) showed adequately low risk of methodological bias. TSK1 57 
(activity avoidance) correlated with WOMAC functional score at 12 months in three studies (r=0.20 58 
p<0.05, R=0.317 p=0.001, and correlation coefficient 0.197 p=0.005). TSK score significantly 59 
correlated with mean active range of motion (ROM) at two weeks (65.98 (SD=14.51) vs 47.35 60 
(SD=14.48) p=0.000), four weeks (88.20 (SD=15.11) vs 57.65 (SD=14.80) p=0.000), and six months 61 
(105.33 (SD=12.34) vs 85.53 (SD=14.77) p=0.000) post-operation. Three post-operative interventions 62 
improved TSK score vs control following TKR: a home-based functional exercise programme (TSK -63 
14.30 (SD=0.80) vs -2.10 (SD=0.80) p<0.001)), an outpatient Cognitive behavioural therapy (CBT) 64 
programme (TSK 27.76 (SD=4.56) vs 36.54 (SD=3.58), and video-based psychological treatment (TSK 65 




Kinesiophobia negatively affects functional outcomes up until one year post-operatively, while active 70 
ROM is reduced up to six months post procedure. Post-operative functional and psychological 71 
interventions can improve kinesiophobia following TKR. 72 
 73 
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Total knee replacement (TKR) is performed to alleviate pain and improve function in 86 
patients with osteoarthritis (OA) [1]. Outcomes following TKR are influenced by surgical 87 
technique, prosthesis design, and patient co-morbidities [2], although the importance of 88 
psychological factors are recognised [2-4]. With the number of total knee replacements 89 
(TKR) and set to double in the United Kingdom between 2010 and 2035 [5], rehabilitation 90 
post-TKR is gaining importance on a population level.  91 
 92 
Post-operative rehabilitation is crucial to improve function and reduce disability following 93 
TKR [6]. Nearly 20% of patients report moderate to severe pain at one year post-operatively 94 
[7]. Those who experience greater pain post-TKR are more reluctant to engage in exercise 95 
with a detrimental effect on their post-operative recovery [8]. The ‘fear avoidance’ model 96 
describes the relationship of behaviour, emotional, and cognitive factors in pain responses. 97 
Two responses to pain have been described: confrontation of pain, leading to reduction of 98 
fear over time and resumption of normal activity; and the avoidance and exacerbation of 99 
fear. Based on this, Kori, Miller and Todd developed the term ‘kinesiophobia’ which 100 
describes an excessive, irrational, and debilitating fear of physical movement and activity 101 
resulting from a feeling of vulnerability to painful injury or re-injury [9-10].  102 
 103 
Kinesiophobia has gained greater attention recently. It has been hypothesised that mal-104 
adaptive cognitive behaviours can create a vicious cycle of pain and disability [6]. 105 
Kinesiophobia can be seen as a normal physiological reaction in the early stages post-106 
surgery, but is associated with the transition from acute to chronic pain and reduced health-107 
related quality of life measures regardless of injury location [11-15]. First investigated in 108 
lower back pain [16], kinesiophobia has subsequently been associated with poorer 109 
functional outcomes in hip arthroplasty, ACL reconstruction, and patellofemoral pain [17-110 
19]. 111 
 112 
With mounting evidence that kinesiophobia results in poorer outcomes in a variety of 113 
injuries and procedures, treatment strategies have gained attention. These have focussed 114 
on both physiological and psychological rehabilitation. Functional exercises have been 115 
shown to provide greater efficacy than isometric muscle exercises and range of motion 116 
exercises [20], while an outpatient-based Pilates programme has proven successful in lower 117 
back pain kinesiophobia [21]. Psychological treatments have focussed on strategies aimed at 118 
decreasing fear of movement [18], including imagining the execution of a motor function 119 
[22]. Although some strategies have been suggested, there are no specific systematic 120 
reviews of these following TKR. 121 
 122 
To date, no systematic reviews have investigated kinesiophobia following TKR specifically. 123 
With an expanding post-operative patient cohort, the ability to understand the role of 124 
kinesiophobia and provide effective treatment to aid rehabilitation is gaining importance. 125 
The aim of this review is two-fold, to evaluate the existing evidence on the effect of 126 
kinesiophobia on outcomes following TKR, and to evaluate published treatments for 127 
kinesiophobia following TKR. 128 
  129 
Materials and Methods 130 
 131 
Search Strategy  132 
A primary search of electronic databases (EMBASE, CINAHL, AMED, PubMed, PEDro and 133 
PsychINFO) via the Healthcare Databases Advanced Search platform was performed from 134 
inception until March 2020. Grey literature and trial registry searches were performed on 135 
OpenGrey, ISRCTN Registry, PDQT Open and the International Clinical Trials Registry 136 
Platform. The following PRISMA compliant search strategy was used for electronic 137 
databases and grey literature: [“kinesiophobia” OR (fear adj2 avoidance) OR (fear adj2 138 
move*) AND (“total knee arthroplasty” OR “total knee replacement” OR “TKR” OR “TKA”)]. 139 
In addition to our primary search, reference lists of all suitable articles were screened for 140 
additional papers. 141 
 142 
Inclusion/Exclusion Criteria 143 
Inclusion criteria: 144 
• Studies recruiting patient having undergone primary TKR 145 
• Kinesiophobia or fear of movement included as a measured variable or outcome 146 
• Kinesiophobia measured using the Tampa Scale of Kinesiophobia (TSK) 147 
• Patient cohort age ³18 years 148 
Exclusion criteria: 149 
• Non-English language papers 150 
  151 
All full-tests that met the eligibility criteria were included in the final review. Study 152 
identification was independently performed by one reviewer (LH) and verified by another 153 
(CD) after reviewing titles and abstracts. The search strategy was run, titles and abstracts 154 
were reviewed, and relevant full papers were extracted. A further round of relevancy of the 155 
full papers was undertaken by three reviewers (OB, LH, CD).  156 
 157 
Data Extraction  158 
Two authors (OB, LH) independently extracted all key data from included studies onto a pre-159 
defined data extraction table. This was then verified by another author (CD). All data were 160 
assessed for homogeneity and study type. Studies were grouped into those investigating the 161 
effect of kinesiophobia on outcomes after TKR, and those investigating treatments for 162 
kinesiophobia after TKR. A data extraction spreadsheet was synthesised to present all key 163 
demographic information and results. Where data were not easily extracted or omitted, 164 
corresponding authors were contacted.  165 
 166 
Methodological Appraisal  167 
Study quality was assessed using the Newcastle Ottowa Scale (NOS) for cohort or case-168 
control study as appropriate, shown in Table 1 and Table 2 respectively.  169 
 170 
All randomised controlled trials (RCTs) were assessed using the Cochrane Collaboration Risk 171 
of Bias (RoB 2.0) tool where five categories (randomisation, blinding, completeness of 172 
outcome data, selection of outcomes reported and other sources of bias) were assessed and 173 
itemized in Table 3. Each study was evaluated against the checklist/tool by two reviewers 174 




Comparison 1: The effect of kinesiophobia on outcome following TKR 179 
 180 
Outcome measures were split into short (less than six months), medium (six-12 months) and 181 
Long term (greater than 12 months) time periods for grouped analysis. Primary outcome 182 
measures consisted of: Functional outcome, measured using various patient-reported 183 
outcome measures (PROMS) and clinical tests. The Western Ontario and McMaster 184 
Universities Osteoarthritis Index (WOMAC) [23], Oxford Knee Score (OKS) [24], Knee Society 185 
Score (KSS) [25], and Knee Injury and Osteoarthritis Outcome Score (KOOS-4) [26] were used 186 
to assess functional outcomes. The secondary outcome measures were pain and range of 187 
motion (ROM). Pain was stratified using either a Visual Analogue Scale (VAS) or a numerical 188 
rating scale. Range of motion was calculated actively or passively using a goniometer. 189 
 190 
Comparison 2: Treatment of kinesiophobia following TKR 191 
 192 
Outcome measures were split into short (<six months), medium (six-12 months) and Long 193 
term (>12 months) time periods for grouped analysis. Various modalities to improve 194 
kinesiophobia following TKR will be assessed. Our primary outcome was TSK score at six 195 
months. The Tampa Scale for Kinesiophobia (TSK) was developed by Miller et al. [27]. TSK is 196 
a self-completed 17-item questionnaire, designed to assess subjective rating of 197 
kinesiophobia. Each item is provided with a four-point Likert scale, with the final score 198 
ranging from 17 to 68, where a greater score indicates a higher degree of kinesiophobia 199 
[27][28]. Studies investigating the role of kinesiophobia used values between 38 and 40 as 200 
‘cut-points’ between high and low TSK scores. There were no secondary outcomes for this 201 
comparison. 202 
 203 
Data Analysis 204 
An assessment of study heterogeneity was made by visual assessment of the data extraction 205 
tables. Data was presented as mean ± standard deviation (SD) where possible. Where the 206 
data were heterogeneous, a narrative review of the evidence was presented. 207 
 208 
  209 
Results 210 
 211 
Search Results 212 
The search strategy identified 82 papers and were all exported as titles and abstracts. 213 
Screening based on abstracts, 35 papers were excluded. 47 full-text papers were retrieved, 214 
and 13 papers were reviewed as shown in a PRISMA flowchart Figure 1. 215 
 216 
Quality Assessment  217 
All 13 papers described their cohorts’ characteristics and eligibility criteria and 218 
demonstrated adequate reporting of background and objectives. The reporting of 219 
methodology was variable. All the cohort studies failed to report how potential sources of 220 
bias would be addressed and how the study size was calculated (Table 1). One study by 221 
Filardo et al [29] described potential bias due to using different prostheses in their cohort 222 
but attributed their robust results to the large cohort. Eight studies failed to report 223 
statistical methods used to examine missing data or loss to follow up and how participants 224 
with missing data may have affected the results. Four studies specified the number of 225 
patients at each stage of their study and whether there were any patients lost to follow up. 226 
Only two papers specified that the investigators were not involved in the patient 227 
questionnaire completion process. No studies reported on whether the investigator 228 
measuring flexion and extension was blinded to other patient factors. Most studies have 229 
demonstrated adequate reporting of their results and discussions. Two papers did not 230 
disclose any funding associated with their study.  231 
 232 
Using NOS, all cohort studies and Unver et al.’s [30] case-control study were of ‘good’ 233 
quality (Table 2). Four RCTs described their randomisation process. The results of the 234 
Cochrane Risk of Bias tool is shown in Table 3. Degirmenci et al [31], Monticone et al [6] and 235 
Cai et al [32] demonstrated low risk of bias, whereas Russo et al [33] failed to describe how 236 
their data were analysed, and whether if it was in accordance with pre-specified analysis 237 
plans.  238 
 239 
Study Design and Demographics 240 
 241 
A total of 1,191 patients were identified, ranging from 31 to 200 per study (Table 4). Russo 242 
et al [33] did not specify the gender split and Body Mass Index (BMI) in their study but 243 
stated that the two groups were homogenous in terms of pre-operative age, gender, 244 
functional and psychological scores. Degirmenci et al [31] did not specify the mean BMI, but 245 
stated BMI over 40 in the exclusion criteria. Of 12 studies, 34.9% (380 of 1,089) were men. 246 
Study follow up duration ranged from no follow up (ie time of discharge) to 36 months.  247 
 248 
Clinical Findings 249 
 250 
Thirteen studies were reviewed, four were RCTs eight were cohort studies and one case-251 
controlled study. Three studies assessed the change in TSK over time as their primary 252 
outcome, six studies measured function as a primary outcome using validated scores such 253 
as WOMAC in four studies, KOOS in one study and OKS in one study. Four studies used 254 
functional assessments such as two- or six-minute walk test (2-MWT/6-MWT), Going Up and 255 
Down Scale (GUDS) and Timed Up and Go Test (TUGT) as their primary outcome. Other 256 
outcome measures include pain measured using a Numerical Rating Scale (NRS) or McGill 257 
Pain Score (MPS) in 13 studies and flexion or change in ROM in seven studies.   258 
 259 
Comparison 1: The role of kinesiophobia in outcomes following TKR  260 
 261 
Primary outcomes: 262 
Functional outcomes were assessed by ten studies (Doury-Panchout et al [34], Kocic et al 263 
[2], Sullivan et al [35], Sullivan et al [36], Filardo et al [37], Guney-Deniz et al [38], Filardo et 264 
al [29], Brown et al [39], Unver et al [30], and Degirmenci et al [31]). The results from these 265 
studies are shown in Table 5.  266 
 267 
Functional outcomes at less than six months:  268 
Six minute walk test (6-MWT) distance was measured by Doury-Panchout et al [34] on 269 
hospital discharge, with TSK cut-point at 40. The less than 40 group had a distance of 309 270 
(SD 83.6), versus the 40 plus group with 264 (SD 96.5), p=0.048. Guney-Deniz et al [38] 271 
measured the 2-MWT and TUGT at day two post-surgery, with a TSK cut-point at 39.5. TSK 272 
<39.5 2-MWT were 36.77 (SD 6.04), versus 39.5 plus at 26.42 (SD 5.07), p<0.01, and TUG for 273 
TSK <39.5 were 51.91 (range 33.56-59.11) versus 51.99 (range 32.7-58.7) (non-significant). 274 
Degirmenci et al [31] measured the 2-MWT and TUGT at days two and five post-surgery, 275 
with mean values of day two and five reported, using a TSK cut-point of 40. TSK <40 2-MWT 276 
were 36.15 (SD 4.16) versus 40 plus at 25.76 (SD 4.5), p<0.001. TUGT for <40 were 44.7 (SD 277 
5.6) versus 48.7 (SD 6.2), p=0.011. Sullivan et al [36] found TSK correlated with function 278 
(r=0.38) at six weeks post op (p<0.005) with Bonferroni corrected alpha set at 0.005. 279 
Regression analysis showed that TSK predicts post-surgical WOMAC physical function score 280 
(beta = 0.24, p=0.06).  281 
 282 
Functional outcomes six-12 months: 283 
Kocic et al [2] measured the OKS at six months, with a TSK cut-point at 38. The TSK <38 284 
group had an OKS of 34.48 (SD 7.93) vs 25.82 (SD 6.90) for the 38 plus group.  285 
Filardo et al [29] found a correlation between TSK1 and Physical Health SF-12 subscale at six 286 
months, p = 0.001, R = −0.334, and a correlation between WOMAC at six months of follow-287 
up (p = 0.005, R = 0.279). At six months, Unver et al [30] found a correlation between TSK 288 
and GUDS r=0.468, p<0.001. 289 
 290 
Functional outcomes at 12 months plus: 291 
TSK was split into its constituent parts, TSK1 (activity avoidance) and TSK 2 (harm) in three 292 
studies. Sullivan et al [35], Filardo et al [29], and Filardo et al [37] found a correlation of 293 
TSK1 to physical function measured by WOMAC score at 12 months (r=0.20 p<0.05, p = 294 
0.001, R = 0.317, and p=0.005 correlation coefficient=0.197 respectively). This was also 295 
proven with multivariate analysis by Filardo et al [37] p=0.011, however no correlation was 296 
found at the final mean three-years follow up by Filardo 2015 [29].  297 
 298 
Secondary outcomes: 299 
 300 
Pain outcomes at less than six months (Table 6) 301 
Guney-Deniz et al [38] had a TSK cut-point of 39.5, and measured pain at day two post-302 
surgery using a VAS. TSK <39.5 had a VAS of 2.3 (range 1.2-4.2)  versus 3.2 (range 1.4-6.3) 303 
for TSK 39.5, p=0.003. They correlated TSK with pain at day two post-surgery r = 0.80, p 304 
<0.001. Degirmenci et al [31] had a TSK cut-point of 40, and measured pain levels Day 5 305 
post-op using a VAS. TSK <40 had a VAS of 4.2 (SD 0.8) versus TSK 40 plus at 6.6 (SD 0.9), 306 
p<0.001. 307 
 308 
Filardo et al [29] correlated TSK1 with day five post-operative pain via numerical rating scale 309 
(p=0.031, R = 0.225).Pain on discharge day for Doury-Panchout et al’s [34] TSK <40 cohort 310 
was 8.9 ± 10.5mm, vs 11.3 ± 12.2 (non-significant). Kocic et al [2] used a numerical rating 311 
scale, with TSK cut-point at 38. Pain at two weeks was 5.03 (SD 1.54) for <38 versus , 6.09 312 
(SD 1.33) for TSK 38 plus, p=0.0123. Pain at four weeks was 3.12 (SD 1.23) for <38 versus 313 
5.00 (SD 1.49) for 38+ (p=0.000). Sullivan et al [36] did not correlate TSK and pain post 314 
operatively using the WOMAC pain score (r=0.31, p<0.005). This remained non-significant 315 
with regression analysis (beta = 0.07).  316 
 317 
Pain outcomes six-12 months (Table 6) 318 
Kocic et al [2] correlated TSK and pain via a numerical rating scale at six months with TSK 319 
cut-point of 38. TSK <38 had pain ratings of 1.81 (SD 1.50), vs 3.24 (SD 1.98), p=0.0035. 320 
Unver et al [30] found a correlation between pain and TSK at six months (r=0.236, p=0.004). 321 
 322 
Pain outcomes 12 months plus: (Table 6) 323 
Sullivan et al [35] did not correlate TSK and WOMAC pain scale at 12 months (r=0.23). TSK 324 
did not correlate significant unique variance to the prediction of follow up pain severity 325 
(beta = 0.10). Filardo et al [29] correlated TSK1 with 12-month post-operative pain via 326 
numerical rating scale (p=0.018, R= 0.234). 327 
 328 
ROM outcomes less than six months (Table 7) 329 
Guney-Deniz et al [38] measured active knee flexion on day two post-operative, with TSK 330 
<39.5 having flexion of 71.67o (SD 8.35o) versus 65.95o (SD 6.73o), p=0.025. TSK was found to 331 
correlate with range of motion at two days post-operative (r=-0.47, p<0.001). 332 
Doury-Panchout et al [34] compared TSK <40 to TSK 40 plus on discharge day, finding 333 
maximum passive flexion of 114.3o (SD 7.3o) in TSK <40 versus 11.34o (SD 9.4o) in 40 plus 334 
(non-significant). Maximum active extension in <40 was -6.7o (SD 5.9o) vs -5.9o (SD 6.5o) for 335 
40 plus (non-significant). Degirmenci et al [31] measured active knee flexion on day five 336 
post-operatively, with a TSK cut-point of 40. TSK <40 had flexion of 84.1o (SD 6.3o) versus 337 
TSK 40 plus at 64.9o (SD 8.1o), p<0.001. 338 
 339 
Kocic et al [2] found those with TSK <38 had active knee flexion of 65.98o (SD 14.51o) at two 340 
weeks versus 47.35o (SD 14.48o) for 38+, p=0.000. At four weeks <38 active knee flexion was 341 
88.20o (SD 15.11o) versus 57.65o (SD 14.80o) in 38 plus, p=0.000.  342 
 343 
ROM outcomes six-12 months (Table 7) 344 
Kocic et al [2] measured active knee flexion at six months, finding TSK <38 at 105.33o (SD 345 
12.34o) versus 85.53o (SD 14.77o), p=0.000. Kocic et al also found a strong negative 346 
correlation between TSK score and flexion at all points assessed (p<0.001).  347 
 348 
Comparison 2: Treatment of kinesiophobia following TKR  349 
 350 
Primary outcome: TSK score 351 
The effect of various interventions to improve kinesiophobia, measured by the TSK scale 352 
was investigated by five studies: Monticone et al [6], Cai et al [32], Russo et al [33], Brown et 353 
al [39], and Degirmenci et al [31]. Results for these can be seen in Table 8. Monticone et al 354 
[6] compared a six-month period of home based functional exercises to standard 355 
physiotherapy following TKR. Pre-TKR, there was no statistical difference between the two 356 
groups (TSK experimental group 34.14 (SD 7.54) versus control 34.40 (SD 5.51), p=0.842). 357 
Significant differences existed between groups at six and 12 months post TKR however: six-358 
months experimental group TSK -14.30 (SD 0.80) versus control -2.10 (SD 0.80) (MD -12.2 (-359 
14.5 to -9.9)) p<0.001; 12 months experimental group -18.30 (SD 0.80) versus control -2.80 360 
(SD 0.80) MD -15.4 (-17.7 to -13.2), p <0.001. 361 
 362 
Cai et al [32] conducted a RCT comparing inpatient physiotherapy plus an outpatient four 363 
week Cognitive behavioural therapy (CBT) programme designed to treat kinesiophobia with 364 
standard inpatient physiotherapy. There was no significant difference between the groups 365 
at baseline (TSK 46.98 (SD 5.44) versus 47.72 (SD 6.17), p=0.526. At six months post TKR, 366 
experimental group TSK was 27.76 (SD 4.56) versus 36.54 (SD 3.58) in the control group. 367 
Analysis revealed a group effect (p<0.001) between CBT and non-CBT groups.  368 
 369 
Video treatment to produce positive insight into kinesiophobia was investigated by Russo et 370 
al [33], pre-operatively and at three months post TKR. Both groups showed a significant 371 
(p<0.001) difference between baseline and follow-up TSK, and there was a significant 372 
difference between video and no video groups at follow up (TSK 24 (SD 5) versus control 29 373 
(SD 5) p<0.01). 374 
 375 
Brown et al [39] investigated the effect of showing patients an intra-operative photograph 376 
of their knee’s maximal passive flexion as an incentive to improve ROM. Post-operatively, 377 
the mean active knee flexion among the photo group was 99o (SD 17.4o) versus 106.1o (SD 378 
14.4o) for the control group, p=0.1. Passive flexion in the photo group was 94.1o (SD 18.5o) 379 
versus 100.9o (SD 15.5o), p=0.14. There were no secondary outcomes for this comparison. 380 
 381 
Degirmenci et al [31] conducted a randomised controlled trial comparing regional 382 
anaesthesia and deep sedation with regional anaesthesia and light sedation, measuring 383 
kinesiophobia with TSK score at days two and five post-operatively. Deep sedation was 384 
defined as Bispectral Index Score (BIS) of 60-70, while light sedation was defined as BIS up 385 
to 80. Significant differences between the two groups were shown at both time points: day 386 
two deep sedation TSK 40.5 (SD 6.1) versus light sedation 46.9 (SD 10.4) (p=0.005); day five 387 
deep sedation TSK 37.7 (SD 5.7) versus light sedation 46.4 (SD 10.0) (p<0.001).  388 
 389 
  390 
Discussion 391 
 392 
In this systematic review, we have found that kinesiophobia, measured by TSK score, 393 
negatively influences functional outcomes following TKR. This was found to be true at all 394 
three time points investigated. Functional outcomes measured included the Two- and Six-395 
Minute Walk Tests (2/6-MWT), the Oxford Knee Score (OKS), the WOMAC functional score, 396 
and the Timed Up-and-Go (TUG test). Only the TUG test at day two post operatively, 397 
measured by Guney-Deniz et al [38], was not significantly different between high-TSK and 398 
low-TSK groups. Multivariate analysis conducted for functional outcomes and TSK score 399 
agreed that a correlation existed. When TSK1 (activity avoidance) and TSK2 (harm) were 400 
separated, it was TSK1 that correlated with WOMAC score at 12 months, but not at mean 401 
three years follow-up.  402 
 403 
Sullivan et al [35], Sullivan et al [36], Filardo et al [37] and Filardo et al [29] found that 404 
kinesiophobia can predict post-surgical function independently of other psychological and 405 
physical variables. It was also demonstrated by Filardo et al  that the effects of 406 
kinesiophobia can be seen for up to one year [37], and although its impact decreases in 407 
longer term follow up, higher TSK scores may still present with lower final outcomes [29].  408 
 409 
Studies differed widely on the correlation between pain and TSK score. While Doury-410 
Panchout et al [34] and Guney-Deniz et al [38] measured pain on day two and discharge 411 
date respectively, finding no significant differences between high-TSK and low-TSK groups; 412 
Degirmenci et al [31] found pain and TSK score correlated at day five post operatively. Kocic 413 
et al [2] found high-TSK and low-TSK groups to be significantly different at two and four 414 
weeks, and six months. This could be explained by a longer hospital stay demonstrated in 415 
kinesiophobic patients, apart from the fact that Sullivan et al [36], Sullivan et al [35], and 416 
Unver et al [30] all found no correlation between TSK and pain score. Again, Filardo et al 417 
[29] found TSK1 significant on day five post operatively but not TSK2. As a result, it is not 418 
clear whether a true statistical correlation between kinesiophobia and pain post-TKR exists 419 
based on our findings. 420 
 421 
There were fewer data sets available for range of motion, but a mixed picture was also 422 
provided by our results. Kocic et al [2] demonstrated active knee flexion to be higher in low-423 
TSK groups at two and four weeks, and at six months with a strong negative correlation at 424 
all points assessed. Guney-Deniz et al [38] Brown et al [39], and Degirmenci et al [31] also 425 
found a correlation between TSK and active knee flexion. However, Doury-Panchout et al 426 
[34] found no significant difference between high-TSK and low-TSK groups in max passive 427 
flexion and max active extension on discharge day, and Filardo et al [29] found no 428 
correlation between TSK1 and TSK2 in active or passive ROM. Measuring outcomes on 429 
discharge day could result in significant length of stay related biases, however. Our evidence 430 
suggests that there may be a negative relationship between active knee flexion and 431 
kinesiophobia, but not all studies are in agreement.  432 
 433 
In our second comparison, increased levels of anaesthetic sedation were correlated with a 434 
reduced TSK score at days two and five post-operatively by Degirmenci et al [31], as well as 435 
superior performance in the 2-MWT and TUGT, and reduced pain. Intra-operative use of 436 
anaesthesia may therefore influence the early post-operative fear avoidance behaviour. 437 
Whether this continues to affect kinesiophobia more long-term is uncertain.   438 
 439 
Our second comparison indicated that three of the four post-operative interventions to 440 
treat kinesiophobia had a positive impact. Home based functional exercises, an outpatient 441 
CBT programme, and video treatment could be used separately or in combination 442 
depending on the individual patient’s needs to improve quality of care for kinesiophobic 443 
patients. Brown et al [39] proved that showing a patient a photograph of their maximal 444 
passive knee flexion in theatre did not improve their active or passive ROM. Kinesiophobia is 445 
defined as an irrational fear, so it makes sense that trying to cure it based on appealing to 446 
rational thought processes may not yield the intended results.  447 
 448 
The three successful interventions focussed on physiotherapy or psychotherapy, and a 449 
combination between the these two may yield the most successful result.  450 
 451 
Using the TSK score has enabled an excellent means of stratifying kinesiophobia, and most 452 
of our papers used it to separate patients into high and low-TSK groups. All included studies 453 
had a threshold within two points of each other, but the decision to choose cut-off points by 454 
individual studies was not completely explained. This raises the possibility that these 455 
decisions may have affected outcomes. Filardo et al [29] split the TSK score into its 456 
component parts, activity avoidance and harm, enabling further analysis. This highlighted 457 
that TSK1 correlates better with pain and function, although this could not be compared to 458 
the cohorts of other studies.  459 
 460 
This systematic review presented with a number of limitations. For example heterogeneity 461 
amongst studies in terms of outcome, whether reporting statistical significance between 462 
two groups or an overall correlation following regression analysis, restricted our ability to 463 
perform statistical comparisons. The statistical reporting of data also varied widely between 464 
studies, with some using standard deviation and others quoting ranges. The discrepancy 465 
between studies’ TSK thresholds also acted to prevent direct comparison between studies 466 




The role of kinesiophobia in outcomes post-TKR is inherently complicated, but our results 471 
indicate that functional outcomes are negatively influenced by its presence at time frames 472 
up to one year. Pain is correlated with kinesiophobia at six months. Active range of motion 473 
is negatively affected by kinesiophobia, but cannot be treated by simply showing patients 474 
that it is possible to achieve good ROM in theatre. Kinesiophobia can be improved through 475 
post-operative functional and psychological interventions such as long term physiotherapy, 476 
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1 ★ ★ ★ ★ ★ ★ ★ ★ 
2 ★ ★    ★  ★ 
3 ★ ★ ★ ★ ★ ★ ★ ★ 
4 ★ ★ ★ ★ ★ ★ ★ ★ 
Comparability 
(max 2) 
        
1 
Outcome  









1 ★ ★ ★ ★ ★ ★ ★ ★ 
2  ★ ★ ★ ★  ★ ★ 
3 ★ ★ ★ ★ ★ ★ ★ ★ 
Total  8 9 8 8 8 8 8 9 
Quality  Good Good  Good  Good  Good  Good  Good  Good  
 506 
Table 1. Selection Q2 (selection of non-exposed cohort). As all participants in these studies were subject to a 507 
TKR, the exposure for the purposes of this review will be defined as a patient scoring highly on the TSK. 508 
Selection Q4, the ‘outcome of interest’ is usually present at start of study (eg pain, range of movement) but 509 
the primary outcome measures are changes in the outcome, therefore we have assumed the ‘outcome of 510 
interest’ is not present at the start.  511 
 512 
 513 
Table 2: Newcastle Ottowa Score for case-controlled studies  514 
 515 




















Total  6 




  519 
Table 3: RoB 2.0 tool 520 
 521 
 Monticone et 
al., 2013 
Cai et al., 
2017 
Russo et al., 
2017 
Degirmenci 
et al. 2020 




L L L L 




L L L L 
Selection of reporting  L L SC L 
Overall  L L SC L 
 522 
Table 3. L = Low risk of bias, SC = some concerns, H = high risk of bias Attempts were made to contact authors 523 
for their study protocol to accurately assess their ‘selection of reporting’. One author responded and stated 524 
their protocol was not written in English and would be difficult to retrieve. 525 
 526 
 527 
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N  89 78 110 120 75 100 200 102 46 101 79 36 60 
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Table 5: Comparison one - TSK and functional outcome results, split into time frames 532 
 533 
Author Doury-Panchout Kocic Sullivan Sullivan Filardo Guney-Deniz Filardo Brown Unver 
Year 2015 2015 2011 2008 2016 2017 2015 2015 2014 
Groups TSK score high and low (cut-off = 40) 








TSK split into subsets 
TSK 1 (activity 
avoidance)  and TSK 2 
(harm) and 
correlation measured 
17 point Turkish version of  TSK Cut-off 
39.5 between high and low 























low TSK (<39.5) (gp 
2) mean TSK 46.01 
+/- 10.25 
high TSK (>39.5) (gp 1) 

















































36.77 +/- 6.04 
TUG 51.99 (32.7-58.7) 









































subscale at 6 
months  p = 
















































































12 months  p 
= 0.005, R = 
−0.277 
  
TSK = Tampa scale of Kinesiophobia, 6MWT = 6-minute walk time, WOMAC score = Western 534 









Table 6: Comparison one - TSK and pain results, split into time frames 544 
Publication 
author Doury-Panchout Kocic Sullivan Sullivan Filardo Guney-Deniz Filardo Brown Unver 
Publication 
year 2015 2015 2011 2008 2016 2017 2015 2015 2014 
Groups TSK score high and low (cut-off = 40) 







TSK split into 
subsets TSK 1 
(activity 
avoidance)  and 





of  TSK. Cut-off 
39.5 between 
high and low 
 
TSK split into 
subsets TSK 1 
(activity 
avoidance)  and 












measured discharge day 
2 weeks, 4 weeks, 6 
months 12 months 6 weeks 
12 months post 
TKR day 2 post-op 
5 days, and 1, 6, 
12 months. Final 
follow up at 
average 3.2 
years 
post op day 1-
4, as well as 
outpatient 













subgroups TSK <40 TSK >=40  TSK <38 TSK >=38 
























TSK 1 (activity 
avoidance), TSK 
























































with post op 
pain (NRS) 5 
























      
TSK1 correlated 
with post op 





 TSK = Tampa scale of Kinesiophobia, NRS = numerical rating scale, VAS = visual analogue 545 
scale  546 
Table 7: Comparison one – TSK and range of motion results, split into time frames 547 
Publication 
author Doury-Panchout Kocic Sullivan Sullivan Filardo Guney-Deniz Filardo Brown Unver 
Publication 
year 2015 2015 2011 2008 2016 2017 2015 2015 2014 
Groups TSK score high and low (cut-off = 40) 






TSK split into 
subsets TSK 1 
(activity 
avoidance)  and 
TSK 2 (harm) and 
correlation 
measured 
17 point Turkish version 
of  TSK. Cut-off 39.5 
between high and low 
TSK split into 
subsets TSK 1 
(activity 
avoidance)  and 












measured discharge day 
2 weeks, 4 weeks, 6 
months 12 months 6 weeks 
12 months post 
TKR day 2 post-op 
5 days, and 1, 6, 
12 months. Final 
follow up at 
average 3.2 years 
post op day 1-
4, as well as 
outpatient 













subgroups TSK <40 TSK >=40  TSK <38 TSK >=38 





















TSK 1 (activity 
avoidance), TSK 2 












































































between TSK1 or 
TSK2 and active 
or passive ROM 
TSK correlation 








































p=0.000        
ROM >12 
months 
         
















Table 8: Comparison two results 564 
Author Monticone et al Cai et al Russo et al 
Year 2013 2017 2017 
Description 
RCT comparing home based functional 
exercises for six months to standard 
physiotherapy (used Italian 13-point 
version of TSK) 
RCT comparing CBT programme with no 
CBT programme 
comparison of video treatment with 

















at discharge from rehab unit (t0), 6 
months after (t1 - when rehab 
programme stopped), and 12 months 
post Dx (t2) 
day 1 or 2 post-TKR, 4 weeks, 6 months 






34.40 +/- 5.51 
(at discharge) p=0.842 
46.98 +/- 
5.44 47,72 +/- 6.17 p=0.526 36 +/- 8 38 +/- 6 p<0.01 
























36.54 +/- 3.58 
(6 months) 
F=33.867, 















RCT = Randomised controlled trial, TSK = Tampa scale of Kinesiophobia, MD = mean 565 
difference, CBT = cognitive behavioural therapy 566 
  567 
Figure 1: Search strategy. PRISMA diagram showing search results and route taken to 568 







  576 
Records identified through 
database searching 
























Additional records identified 
through other sources 
(n = 77) 
Records after duplicates removed 
(n = 82) 
Records screened 
(n = 47) 
Records excluded 
(n = 18) 
Full-text articles assessed 
for eligibility 
(n = 29) 
Full-text articles excluded, 
with reasons 
(n = 16) 
Studies included in 
qualitative synthesis 
(n = 13) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 13) 
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